Nanologica Announces Outcome of Rights Issue

The Board of Directors of Nanologica AB (publ) (“Nanologica” or the “Company”) today announces the outcome of the Company’s rights issue of units of approximately SEK 110.5 million (the “Rights Issue”), for which the subscription period ended on 17 November 2026. The Rights Issue has been subscribed to approximately 38.76 percent with and without the support of unit rights, of which approximately 38.69 percent was subscribed for with the support of unit rights and approximately 0.07 percent was subscribed for without the support of unit rights. In addition, guarantee commitments will be called upon for a total of 25,502,036 units, corresponding to approximately 38.78 percent of the Rights Issue, of which 1,113,990 units relate to the bottom guarantee commitment and 24,388,046 units to the top guarantee commitments. Including the called upon guarantee commitments, the Rights Issue is thus subscribed to a total of approximately 77.55 percent. Through the Rights Issue, the Company will receive approximately SEK 85.7 million before deduction of issue costs and set-off of claims.

About the Rights Issue

Those who on the record date of 30 October 2026 were registered as shareholders in the share register maintained by Euroclear Nordics AB received one (1) unit right for each existing share. Five (5) unit rights entitled the holder to subscribe for one (1) new unit, consisting of ten (10) new shares. The subscription price was SEK 1.68 per unit, corresponding to SEK 0.168 per share. In addition, it was possible to apply for subscription of units without the support of unit rights. The Rights Issue was covered by subscription commitments and guarantee commitments of approximately SEK 85.7 million in total, corresponding to approximately 77.55 percent of the Rights Issue.

Final outcome

In the Rights Issue, 25,443,368 units were subscribed for with the support of unit rights, corresponding to approximately 38.69 percent of the Rights Issue. In addition, 43,997 units were subscribed for without the support of unit rights, corresponding to approximately 0.07 percent of the Rights Issue. Together, subscription with and without the support of unit rights thus corresponds to approximately 38.76 percent of the Rights Issue.

As a result of the level of subscription, the bottom guarantee commitment provided by Bergs Securities AB (“Bergs Securities”) will be called upon for 1,113,990 units, corresponding to approximately 1.69 percent of the Rights Issue. Furthermore, top guarantee commitments from the Chairman of the Board Thomas Eldered (via T&M Participation AB), Ardena Gent NV (“Ardena”) and the Company’s partner Sterling Pharma Solutions (“Sterling”) will be called upon for a total of 24,388,046 units, corresponding to approximately 37.09 percent of the Rights Issue. Including the called upon guarantee commitments, the Rights Issue is thus subscribed to a total of approximately 77.55 percent.

Payment for units allotted to Sterling in the Rights Issue will be made by set-off of a claim of approximately SEK 13.9 million that Sterling holds against the Company. Ardena will pay part of the subscription proceeds for allotted units by set-off of a claim against the Company of approximately SEK 1.3 million. In total, set-offs in the Rights Issue amount to approximately SEK 15.2 million.

Through the Rights Issue, Nanologica will receive approximately SEK 85.7 million before deduction of issue costs and set-off of claims. The costs related to the Rights Issue are estimated to amount to a total of approximately SEK 5.2 million in the event that Bergs Securities chooses cash guarantee compensation in full.

 Notification of allotment

Allotment of units has been made in accordance with the allotment principles set out in the information document published on 2 November 2026. Payment for subscribed and allotted units that is not made by set-off shall be made in cash in accordance with the instructions on the contract note. Investors who have subscribed for units through a nominee will receive notification of allotment in accordance with the respective nominee’s procedures. Only those who have been allotted units will be notified.

 Trading in BTU

Trading in BTU (paid subscribed units) is currently taking place on Nasdaq Stockholm and will cease after the Rights Issue has been registered with the Swedish Companies Registration Office. BTU will then be converted into shares. The last day of trading in BTU is expected to be on or around 1 December 2026.

 Guarantee compensation

For the top guarantee commitments from Thomas Eldered (via T&M Participation AB) and Ardena, guarantee compensation of 14 percent of the guaranteed amount is payable in the form of newly issued units. Sterling’s top guarantee commitment is free of charge. For Bergs Securities’ bottom guarantee commitment, guarantee compensation of 10 percent of the guaranteed amount is payable in cash or, at Bergs Securities’ option, 14 percent of the guaranteed amount in the form of newly issued units. Bergs Securities shall, no later than five (5) banking days after the end of the subscription period, notify the Company of the extent to which the guarantee compensation is to be paid in cash and in the form of newly issued units, respectively. The guarantee compensation may be paid in whole or in part in either form. The subscription price for units issued as guarantee compensation shall be set at SEK 1.68 per unit, corresponding to the subscription price in the Rights Issue. The guarantee compensation to T&M Participation AB is conditional upon approval by the Extraordinary General Meeting on 30 November 2026. A resolution on a directed issue of units as guarantee compensation will be announced in a separate press release.

 Number of shares, share capital and dilution

Through the Rights Issue, the number of shares in Nanologica will increase by 509,894,010 shares and the share capital will increase by SEK 10,197,880.20. Following the Rights Issue, the number of shares in the Company will amount to 838,663,852 shares and the share capital will amount to SEK 16,773,277.04. The Rights Issue entails a total dilution effect of approximately 60.80 percent of the capital and votes following registration with the Swedish Companies Registration Office.

 Advisers

Nanologica has engaged Redeye AB, Bergs Securities AB and Navia Corporate Finance AB as Joint Bookrunners, and Advokatfirman Lindahl KB as legal adviser in connection with the Rights Issue. Bergs Securities AB is also acting as issuing agent in connection with the Rights Issue.

 

2026-11-19 Nanologica Announces Outcome of Rights Issue

Share this: